Search
Safflower oil
go.drugbank.com/drugs/DB09446ApprovedInvestigationalWithdrawnSafflower (_Carthamus tinctorius_ L) is a herbaceous plant in the Asteraceae family. … Gamma linolenic acid (GLA) safflower oil is marketed as an over-the-counter dietary supplement.
Oliceridine
go.drugbank.com/drugs/DB14881ApprovedInvestigational[A218026, A218031] By acting as a biased agonist, oliceridine provides comparable analgesia compared with traditional opioids such as [morphine] at a comparable or decreased risk of opioid-related adverse … [A218026, A218031, A218036, A218041, A218046] Oliceridine (formerly known as TRV130) is a "biased agonist" at the μ-opioid receptor by preferentially activating the G-protein pathway with minimal receptor
SLV-334
go.drugbank.com/drugs/DB15356InvestigationalSLV-334 is under investigation in clinical trial NCT00735085 (A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.).
LY-2624803
go.drugbank.com/drugs/DB15092InvestigationalLY-2624803 is under investigation in clinical trial NCT01236105 (Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject).
Zuretinol acetate
go.drugbank.com/drugs/DB12112InvestigationalZuretinol acetate has been used in trials studying the treatment of Impaired Dark Adaptation, RP (Retinitis Pigmentosa), Retinitis Pigmentosa (RP), and LCA (Leber Congenital Amaurosis).
Categories: Compounds used in a research, industrial, or household settingVelufenacin
go.drugbank.com/drugs/DB21473InvestigationalVelufenacin has a monoisotopic molecular weight of 362.12 Da. … Velufenacin is a small molecule drug. The usage of the INN stem '-fenacin' in the name indicates that Velufenacin is a muscarinic receptor antagonist.
Remetinostat
go.drugbank.com/drugs/DB14869InvestigationalRemetinostat is under investigation in clinical trial NCT02213861 (Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma).
R906289
go.drugbank.com/drugs/DB19126InvestigationalR906289 is under investigation in clinical trial NCT05308264 (Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)).
Ritonavir
go.drugbank.com/drugs/DB00503ApprovedInvestigationalIt is now more commonly used as a booster of other protease inhibitors and is available in both liquid formulations and as capsules. … Ritonavir is found in a fixed-dose combination product with [DB09296], [DB09183], and [DB09297] as the FDA-approved product Viekira Pak.